Circulation

Covered Stent Correction for Sinus Venosus Atrial Septal Defects, an Emerging Alternative to Surgical Repair: Results of an International Registry

BACKGROUND: Covered stent correction for a sinus venosus atrial septal defect (SVASD) was first performed in 2009. This innovative approach was initially viewed as experimental and was res...

Correction to: Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy

A Young Man With Syncope: What Is the Diagnosis?

The Mysterious Masks of Hypercholesterolemia: A Unique Clinical Case

Covered Stent Treatment for Sinus Venosus Atrial Septal Defects: Early Promise and Potential Limitations

Response by Chan et al to Letters Regarding Article, “Race and Sex Differences in the Association of Bystander CPR for Cardiac Arrest”

The Role of Race in Cardiovascular Disease Risk Prediction

Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology

Collaborators: Larry A. Allen, MD, MHS, FAHA, FACC; Mats Börjesson, MD, PhD, FACC; Alan C. Braverman, MD, FACC; Julie A. Brothers, MD; Silvia Castelletti, MD, MSc, FESC; Eugene H. Chung, M...

Letter by Tamirisa et al Regarding Article, “Race and Sex Differences in the Association of Bystander CPR for Cardiac Arrest”

Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy

BACKGROUND: Classically, hypertrophic cardiomyopathy (HCM) has been viewed as a single-gene (monogenic) disease caused by pathogenic variants in sarcomere genes. Pathogenic sarcomere varia...

Letter by Shang et al Regarding Article, “Race and Sex Differences in the Association of Bystander CPR for Cardiac Arrest”

Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study

BACKGROUND: Bleeding after starting anticoagulation for atrial fibrillation (AF) may be the first sign of malignancy, especially in elderly individuals. There are no recommendation...

Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction

BACKGROUND: Periprocedural myocardial injury (PMI) with or without type 4a myocardial infarction (MI) might occur in patients with non–ST-segment–elevation MI (NSTEMI) after percutaneous c...

Risk of Cancer in Newborns With Congenital Heart Disease and Their Mothers: A Nationwide Cohort Study